A new study reveals that one-third of children with juvenile idiopathic arthritis experience growth and pubertal disturbances ...

Non-pharmacological interventions play a big role in managing rheumatoid arthritis (RA) symptoms and improving quality of ...

Efforts to more precisely select appropriate therapy for individual patients with rheumatoid arthritis have not yet yielded a ...

Lags in Psoriatic Arthritis vs Rheumatoid Arthritis Care Patients ... is linked to higher odds of non-remission in patients with juvenile idiopathic arthritis at 18 years after disease onset ...

Our 17-month-old baby is being investigated for juvenile arthritis. The doctors think that the most likely diagnosis is Still's disease. But nobody seems to know what his future holds or what we ...

Rheumatoid arthritis (RA) commonly causes joint pain, swelling, and inflammation. However, some people with RA will develop skin rashes. These can occur due to hives, vasculitis, and many other ...

The FDA has accepted Yuflyma as an interchangeable biosimilar to adalimumab for the treatment of multiple chronic inflammatory diseases, Celltrion USA announced in a press release.A high-concentration ...

More than two million Australians have arthritis, a condition that causes joint pain and swelling. But many people don’t ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesCompany aims to accelerate access to much-needed biosimilar to reference ...